secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001104659-24-030064
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health extinguishes $10M royalty with Streeterville via Series J Preferred; exchanges PIPE warrants for common
--------------------------------------------------------------------------------

- Exchanged $10M March 2021 Royalty Interest with Streeterville for 179.3822 shares of Series J Preferred Stock.
- Series J Preferred has 0% dividend first 2 years, then 10%/15%; non-convertible but exchangeable by company at Minimum Price.
- PIPE Warrants to purchase up to 7,535,000 shares exchanged for 18,837,500 common shares at 1-for-2.5 ratio.
- PIPE Exchange Shares subject to 12-month lock-up; other equity of PIPE investors locked 6 months.
- Series J Preferred includes covenants restricting equity issuances >$15M without holder consent and limits on asset dispositions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000110465924030064/0001104659-24-030064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000110465924030064/tm247635d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-030064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer